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    Bioactive molecules can be considered to be comprised of core 
scaffolds displaying pharmacophoric groups to enable them to 
interact with their target receptor. Glycoproteins, for example, 
can contain multiple carbohydrate groups on a protein surface 
which are involved in multivalent interactions with lectins that 
can alter a variety of cellular and physiological events.1  
Multivalent carbohydrates can attain high affinity for lectins 
through the glycoside cluster effect2 or they can be involved in 
promoting the cross-linking of glycoproteins which can lead to 
amplification as well as the protraction of signalling events.3  The 
design and synthesis of multivalent carbohydrates is relevant in 
lectin ligand development and a number of factors are considered 
important. These include the valency (bi, tri, tetra etc.) and also 
the nature of scaffold4 used to display the carbohydrates.  Other 
groups can be appended to the scaffold to improve the affinity of 
the molecule, or multiple carbohydrates can be strategically 
located on scaffolds to influence geometric properties.5 
   As part of an interest in glycoclusters, which contain at least 
two carbohydrate residues, we have been involved in the 
synthesis of glycoclusters that have geometric constraints and 
have investigated a number of scaffolds in this respect. These 
include glycophanes, terephthalamides6 and tetraphenylethylene,7 
and has led to the identification of inhibitors of biomedically 
important lectins such as galectins8 and the macrophage 
galactose-C-type lectin.6 Herein, we have taken advantage of 
coiled coil design principles to generate self-assembled coiled 
coil type glycoproteins that display three lactose residues and are 
thus trivalent.  Left handed α-helical trimeric coiled coils, on 
which our designs are based, have previously been designed with 
a metal binding centre to self-assemble in the presence of a 
trivalent lanthanide for MRI applications.9  However, self-
assembling trimeric coiled coils which do not need a metal ion 
for coordination, are also known and are attractive as scaffolds as 
they mirror native protein architectures.10 Recent reports on 
multiply O-glycosylated dimeric coiled coils,11,12,13 including 
some that interact with asialoglycoprotein receptors, has 
prompted us to report our synthesis of N-lactosylated α-helical 
trimeric coiled coils.  The designed α-helical coiled coil scaffold 
presents the lactose residues14 on the outermost surface, either in 
the final heptad towards the N-terminus, where there is greater 
flexibility, or more centrally in the penultimate heptad. We have 
recently shown that coiled coil functionality can be highly 
dependent on which heptad is modified.15 
Firstly, a monomeric peptide was designed using the heptad 
repeat approach (a seven amino acid repeating sequence with 
positions identified by letters a-g).16 The sequence Ac-
G(IaAbAcIdEeQfKg)4G-NH2 was used as the peptide template. 
Isoleucine (Ile, I) residues were positioned in a and d sites 
creating the hydrophobic core whilst at the same time 
encouraging the formation of a trimeric coiled coil.10 Alanine 
(Ala, A) residues in the b and c locations encourage helical 
formation.17 Glutamate (Glu, E) and lysine (Lys, K), in e and g 
positions respectively, form favourable interhelical electrostatic 
interactions between their side chains.9   Glutamine (Gln, Q), a 
solubilising neutral residue, is generally introduced at position f. 
The f site is solvent exposed and was identified as the ideal 
location to incorporate a glycosylated amino acid.  Thus 
lactosylated asparagine was incorporated at this location. 
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Scaffold design, synthesis and application is relevant for biomedical research. For example, 
multivalent interactions, such as those between cell surface glycoproteins and lectins can 
influence the potency and duration of signalling. The spacing between carbohydrates on their 
native protein scaffold could be important.  Herein, the coiled coil design principle is used to 
generate synthetic coiled coil type glycoproteins, where three lactose residues are grafted to the 
coil via N-linkages to asparagine.  Molecular modelling indicates that the distance between the 
galactose anomeric carbon atoms on the neoglycoproteins is ~30 Å.  The inclusion of lactose 
was accommodated in both the final heptad towards the N-terminus, or more centrally in the 
penultimate heptad.  In either case, neither the helicity nor the assembly to the trimeric form was 
unduly altered by the presence of the disaccharide.  
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Figure 1. Structure of glycosylated peptides, SS3 and SS4 and non-glycosylated peptide, SS Control.
In addition, one of the glutamine residues at position f was 
replaced with a tryptophan residue (Trp, W). The presence of 
which enables the concentration of the peptide to readily be 
determined by UV spectroscopy as Trp is a natural chromophore 
absorbing light at 280 nm (ε280 = 5690 M−1 cm−1). 
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Scheme 1. Synthesis of 3 from azide 1  
The lactosylated asparagine 3, needed for solid phase peptide 
synthesis (SPPS), was prepared using a modification of the 
procedure from Liskamp18 (Scheme 1).  The known beta azide 1 
was reduced to amine 2 using palladium on carbon in ethyl 
acetate in the presence of hydrogen.  This reduction gave a 9:1 
mixture of anomers (β:α) that could not be separated by 
chromatography. The use of the Adams catalyst in THF for the 
hydrogenation reaction gave the same product mixture, but in 
lower yield. Coupling of the mixture of amines, with 
appropriately protected aspartic acid (Scheme 1) in the presence 
of 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ) as 
the coupling agent afforded two anomeric amides that could be 
separated by chromatography. This gave the desired β-
lactosamide, which was treated with TFA to cleave the t-Bu ester 
and afforded 3.  This preparation was carried out on an 
approximately 7 g scale.   
 
    Next the synthesis of the 30 amino acid containing 
glycopeptide was performed by automated microwave assisted 
SPPS using Fmoc protected amino acids. Rink amide MBHA 
resin was used as the solid phase for the SPPS, performed on a 
0.25 mM scale.  Automated synthesis was carried out up to the 
point of introduction of the lactose containing residue. The 
introduction of the modified lactosylated amino acid 3 into the 
growing peptide was performed ‘offline’ in order to be able to 
carry out the coupling reaction of the lactose derivative over a 
longer reaction time and to monitor the incorporation of 3 into 
the peptide using the Kaiser test protocol.19 Acetylation of the 
uncoupled free amines after the addition of the modified amino 
acid was carried out so as to render any free amines unreactive.  
After incorporation of the lactosylated amino acid, the remaining 
peptide synthesis was accomplished by automated SPPS. 
    The first glycosylated peptide (SS3, Ac-G IAAIEQK 
IAAIEQK IAAIEXK IAAIEWK G-NH2, where X = lactosylated 
asparagine) was synthesised with the tryptophan positioned in the 
fourth and final heptad and with the lactose positioned in the 
third heptad (Figure 1). The second glycosylated peptide (SS4, 
Ac-G IAAIEQK IAAIEWK IAAIEQK IAAIEXK G-NH2, X = 
lactosylated asparagine) had tryptophan positioned in the second 
heptad whilst the lactose was located in the fourth.  The non-
glycosylated peptide (SS Control, Ac-G IAAIEQK IAAIEQK 
IAAIEQK IAAIEWK G-NH2) had tryptophan located in the 
fourth heptad, analogous to SS3, as shown in Figure 1. It was 
found that coupling of the lactosylated amino acid in SS3 was 
slow and the yields were lower, based on HPLC analysis, when 
compared to amino acids that did not contain the lactose residue. 
Peptide aggregation and/or the bulky nature of the lactose moiety 
may have impaired the efficiency of the coupling.  Therefore, 
SS4 was synthesised, in which the lactosylated asparagine was 
introduced earlier on in the peptide synthesis (peptides are 
synthesised from the N-terminus to the C-terminus), as it was the 
first f site and the third amino acid residue, to be introduced.  
This led to enhanced coupling efficiency and an improved yield 
with respect to SS3.  
After cleavage of the glycosylated peptide from the solid support, 
both glycosylated peptides were subjected to reaction with 
NaOMe in methanol (pH 10), under stirring for 1 h. These 
conditions facilitated efficient removal of the acetate protecting 
groups from the lactose moieties. Amberlite H+ resin was used to 
acidify the resulting mixture to pH 7 during work up. The 
glycopeptides were purified via preparative C18 RP-HPLC and 
subsequently analysed by ESI-MS (Figure 2). 
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Figure 2. Analytical C18 HPLC trace of SS3 after RP-HPLC.   
Electrospray ionisation MS showed a peak for the peptide at 
[M+H]+  3556.72.  Similar HPLC and MS analysis was carried 
out for SS4 and is included in the ESI.   
 
 
    Figure 3. Circular dichroism spectroscopy of 30 µM solutions 
of SS3, SS4 and SS Control monomer, in 5 mM HEPES buffer 
pH 7. 
    Both the glycosylated peptides and the control peptide were 
analysed using circular dichroism (CD) spectroscopy and the data 
obtained are presented in Figure 3. The CD spectra showed 
characteristic minima at 222 and 208 nm, consistent with 
formation of the α-helical coiled coil.  The % folding of these 
coiled coils was determined from the intensity at 222 nm and was 
consistent with SS Control being 87% folded. Both glycosylated 
peptides are slightly less folded, but still consistent with a well 
folded coiled coil (SS4 78%, and SS3 75%). The self-assembling 
characteristics of the glycoclusters and the non-glycosylated 
peptide were studied using analytical ultracentrifugation (AUC). 
Sedimentation equilibrium curves were analysed using a 
modified form of the INVEQ algorithm,20 adapted to estimate 
monomer-dimer-trimer stoichiometry. These data showed the 
presence of a small amount of monomer for both the SS Control 
and SS4 (circa 5 %).   The glycosylated peptide SS3 with the 
sugar moiety positioned in the third heptad showed exclusive 
trimer formation, with no monomer or dimer species detected. 
The data obtained from the analytical ultracentrifugation shows 
that the coiled coils can tolerate the disaccharide moieties without 
disrupting the self-assembly into trimers,  
Molecular modelling was used to estimate possible distances 
between the β-galactose anomeric carbon atoms in both SS3 and 
SS4 (Figure 4).   The distance between these carbon atoms was 
~30 Å in both structures, consistent with the different structures 
involving a ~10 Å linear translation (one heptad) along the coiled 
coil scaffold.  These inter-galactose distances are greater than 
those found in other glycoclusters prepared in our group to date 
and greater than those found in tri-antennary glycans (~20 Å).  In 
SS3, as expected there is a larger portion of peptide flanking 
either side of the lactose residues, while in SS4 this is reduced, 
which may in turn influence lectin binding to the disaccharide 
residue.   
 
 
Figure 4.   Graphical representations of SS3 (left) and SS4 
(right) are shown, where the lactose residues project towards the 
exterior of the coiled coil.  The peptide component is depicted in 
ribbons with the conjugated lactose residues shown as space 
filling models   The distance between the β-galactose anomeric 
carbon atoms in both SS3 and SS4 is ~30 Å.  The models of SS3 
and SS4 were built using Maestro and structures were energy 
minimised in Macromodel using OPLSAA force field 
(www.schrodinger.com).  Angle constraints (C1-C1-C1) were 
applied between the galactose anomeric carbons of 60º during 
energy minimisation. 
In summary, this research has provided glycoclusters based on 
protein scaffolds for biological evaluation, the results of which 
will be presented in due course.  These agents will be compared 
with glycoclusters based on other synthetic scaffolds.  The N-
glycoslated lactose residues have been found to be well tolerated 
in de novo peptide design and not to prevent helix formation or 
alter trimerisation of the coils.  This will inform future design21 of 
neoglycoproteins with a view to developing applications.    
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